Your browser doesn't support javascript.
loading
Combined local therapy and CAR-GPC3 T-cell therapy in advanced hepatocellular carcinoma: a proof-of-concept treatment strategy.
Shi, Yaoping; Shi, Donghua; Chi, Jiachang; Cui, Dan; Tang, Xiaoyin; Lin, Yan; Wang, Siying; Li, Zonghai; Jin, Haojie; Zhai, Bo.
Afiliación
  • Shi Y; Department of Interventional Oncology, State Key Laboratory of Systems Medicine for Cancer, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
  • Shi D; Department of Interventional Oncology, State Key Laboratory of Systems Medicine for Cancer, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
  • Chi J; Department of Interventional Oncology, State Key Laboratory of Systems Medicine for Cancer, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
  • Cui D; Department of Interventional Oncology, State Key Laboratory of Systems Medicine for Cancer, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
  • Tang X; Department of Interventional Oncology, State Key Laboratory of Systems Medicine for Cancer, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
  • Lin Y; Department of Interventional Oncology, State Key Laboratory of Systems Medicine for Cancer, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
  • Wang S; Shanghai Cancer Institute, State Key Laboratory of Systems Medicine for Cancer, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
  • Li Z; Shanghai Cancer Institute, State Key Laboratory of Systems Medicine for Cancer, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
  • Jin H; CARsgen Therapeutics Ltd., Shanghai, P. R. China.
  • Zhai B; Shanghai Cancer Institute, State Key Laboratory of Systems Medicine for Cancer, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
Cancer Commun (Lond) ; 43(9): 1064-1068, 2023 09.
Article en En | MEDLINE | ID: mdl-37478283

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: Cancer Commun (Lond) Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: Cancer Commun (Lond) Año: 2023 Tipo del documento: Article
...